RxDoctor Payments Data

Daniel Wollin, MD

Urology · West Roxbury, MANPI 1629360714

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $58,181 of the $62,074 with a category attached, or 93.7%. Boston Scientific accounts for 91.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $21,013 and has fallen 62.5% since, to $7,889 in 2025. Among urology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$62,074in general payments, 2019–2025

Across 86 payments — averaging $721.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$56K
  • Ambu A/s$2K
  • Olympus Medical Systems Corporation$2K
  • Olympus Corporation Of The Americas$766
  • BD$419
  • Calyxo, Inc.$164
  • plus $213 from 2 others

What the payments were for

  • Consulting fees$58,18194%
  • Speaking & faculty fees$8001%
  • Travel & lodging$1,3882%
  • Food & beverage$1,7053%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$62,074 in reported general payments places this provider in the 95th percentile of 327 urology providers in Massachusetts.

See all urology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$195,142
Medicare patients
441
Services billed
1,138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron57$34,967
GemtesaVibegron20$16,315
Potassium Citrate ErPotassium Citrate33$4,024
Tamsulosin Hcl187$2,186
Finasteride120$1,529
Trospium Chloride27$1,081
Alfuzosin Hcl ErAlfuzosin Hcl16$499
Cefpodoxime Proxetil11$397
Allopurinol14$106
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$78
Ciprofloxacin Hcl23$72

Paid to pharmacies, not to this prescriber.

Other urology in West Roxbury

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →